Human Bone Morphogenetic Protein 2 Contains a Heparin‐Binding Site which Modifies Its Biological Activity

FEBS Journal - Tập 237 Số 1 - Trang 295-302 - 1996
Rainer Ruppert1, Elke Hoffmann1, Walter Sebald1
1Theodor‐Boveri‐Institut für Biowissenschaften (Biozentrum) der Universität Würzburg, Physiologische Chemie II, Würzburg, Germany

Tóm tắt

Bone morphogenetic protein 2 (BMP‐2) plays a decisive role during bone regeneration and repair as well as during various stages of embryonal development. A cDNA encoding mature human BMP‐2 could be efficiently expressed in Escherichia coli, and after renaturation a dimeric BMP‐2 protein of Mr 26000 was prepared with a purity greater 98%. The recombinant BMP‐2 was functionally active as demonstrated by the induction of alkaline phosphatase activity in the C3H10T1/2 fibroblast cell line (EC50 of 70 nM) and proteoglycan synthesis in embryonic chicken limb bud cells (EC50 of 15–20 nM). A peptide 1–17 representing the N‐terminal basic part of BMP‐2 as well as heparin increased the specific activity of the protein about fivefold in the limb bud assay. These observations suggested that the N‐terminal reduce the specific activity of BMP‐2, probably by interacting with heparinic sites in the extracellular matrix. This conclusion was supported by a variant EHBMP‐2, where the N‐terminal residues 1–12 of BMP‐2 had been substituted by a dummy sequence of equal length and which showed an EC50 value of around 1 nM which was affected neither by heparin nor by peptide 1–17. A physical interaction between BMP‐2 and heparin could be seen in biosensor experiments, where BMP‐2 bound to immobilized heparin with a dissociation constant, Kd, of approximately 20 nM, whereas the heparin‐binding of variant EHBMP‐2 was negligible. These results identify the basic N‐terminal domains of dimeric BMP‐2 as heparin‐binding sites that are not obligatory for receptor activation but modulate its biological activity.

Từ khóa


Tài liệu tham khảo

10.1016/0012-1606(77)90110-5

10.1016/S0934-8832(11)80234-9

10.1016/0092-8674(94)90295-X

10.1016/0955-2235(94)90020-5

10.1161/01.ATV.9.1.21

10.1016/0014-4827(90)90318-5

10.1016/0012-1606(91)90242-U

10.1073/pnas.87.24.9843

Cerletti N., 1991, European Patent Application 0433 225 Al.

10.1016/S0014-4827(05)80078-3

10.1006/excr.1993.1127

10.1073/pnas.89.24.11740

10.1126/science.1631557

10.1038/365644a0

10.1038/372266a0

10.1016/0092-8674(94)90409-X

10.1002/jmor.1050880104

10.3109/08977199209046403

10.1152/physrev.1991.71.2.481

10.1083/jcb.127.6.1755

10.1016/S0006-291X(05)80208-6

10.1016/0168-9525(94)90014-0

10.1128/mcb.14.9.5961

10.1016/0092-8674(95)90293-7

10.1016/S0021-9258(18)80003-5

10.1021/bi00071a026

10.1006/abio.1994.1105

10.1016/0092-8674(93)90127-C

10.1016/0969-2126(93)90029-G

10.1038/361068a0

Özkaynak E., 1992, Osteogenic protein‐2. A new member of the transforming growth factor‐β superfamily expressed early in embryogenesis, J. Biol. Chem., 267, 25229, 10.1016/S0021-9258(19)74028-9

10.1126/science.7536345

10.1073/pnas.90.7.2905

10.1083/jcb.119.6.1721

10.1016/0092-8674(94)90294-1

Perides G., 1994, Regulation of neural cell adhesion molecule and L1 by the transforming growth factor‐β superfamily. Selective effects of the bone morphogenetic proteins, J. Biol. Chem., 269, 765, 10.1016/S0021-9258(17)42416-1

10.1016/0167-4781(91)90026-I

10.1016/0955-0674(92)90110-X

10.1016/0959-437X(94)90141-O

10.1002/aja.1002000203

Roghani M., 1994, Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding, J. Biol. Chem., 269, 3976, 10.1016/S0021-9258(17)41730-3

10.1016/0168-9525(92)90063-A

10.1016/0092-8674(95)90292-9

10.1016/S0021-9258(19)38285-7

10.1073/pnas.90.13.6004

10.1073/pnas.78.12.7599

10.1038/358430a0

10.1016/S0021-9258(19)61960-5

10.1006/bbrc.1994.1179

10.1016/0092-8674(94)90032-9

10.1021/bi00190a028

10.1002/j.1460-2075.1984.tb02271.x

10.1016/S0021-9258(17)32506-1

10.1210/en.130.3.1318

10.1001/archotol.1991.01870220049009

10.1126/science.150.3698.893

Urist M. R., 1982, A bovine low molecular mass bone morphogenetic protein (BMP) fraction, Clin. Orthop., 162, 219, 10.1097/00003086-198201000-00037

10.1016/S0092-8674(05)80083-2

10.1073/pnas.85.24.9484

10.1073/pnas.87.6.2220

10.1111/j.1432-1033.1989.tb14647.x

10.1002/mrd.1080320212

10.1126/science.3201241

10.1083/jcb.113.3.681

10.1006/bbrc.1994.2898

10.2106/00004623-199274050-00005

Thông tin
Thông tin xuất bản

FEBS Journal

Tập 237 Số 1

295-302

Thông tin tác giả